An otorhinolaryngological tissue penetration study of T-4288 in patients scheduled for surgery

Trial Profile

An otorhinolaryngological tissue penetration study of T-4288 in patients scheduled for surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Solithromycin (Primary)
  • Indications Otitis media; Sinusitis; Tonsillitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Toyama Chemical
  • Most Recent Events

    • 11 Jan 2017 Status changed from recruiting to completed.
    • 14 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top